Cargando…
Case report: apixaban‐induced thrombocytopenia
Apixaban is a relatively new drug, and its safety profile is still being established. Thrombocytopenia is an uncommon, but life‐threatening side effect with no previous published case repots. Clinicians must be aware of this and exercise caution particularly as some studies hint that it may be used...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331230/ https://www.ncbi.nlm.nih.gov/pubmed/28265388 http://dx.doi.org/10.1002/ccr3.809 |
_version_ | 1782511332617093120 |
---|---|
author | Snellgrove, Oliver |
author_facet | Snellgrove, Oliver |
author_sort | Snellgrove, Oliver |
collection | PubMed |
description | Apixaban is a relatively new drug, and its safety profile is still being established. Thrombocytopenia is an uncommon, but life‐threatening side effect with no previous published case repots. Clinicians must be aware of this and exercise caution particularly as some studies hint that it may be used in the management of HIT. |
format | Online Article Text |
id | pubmed-5331230 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-53312302017-03-06 Case report: apixaban‐induced thrombocytopenia Snellgrove, Oliver Clin Case Rep Case Reports Apixaban is a relatively new drug, and its safety profile is still being established. Thrombocytopenia is an uncommon, but life‐threatening side effect with no previous published case repots. Clinicians must be aware of this and exercise caution particularly as some studies hint that it may be used in the management of HIT. John Wiley and Sons Inc. 2017-02-01 /pmc/articles/PMC5331230/ /pubmed/28265388 http://dx.doi.org/10.1002/ccr3.809 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Snellgrove, Oliver Case report: apixaban‐induced thrombocytopenia |
title | Case report: apixaban‐induced thrombocytopenia |
title_full | Case report: apixaban‐induced thrombocytopenia |
title_fullStr | Case report: apixaban‐induced thrombocytopenia |
title_full_unstemmed | Case report: apixaban‐induced thrombocytopenia |
title_short | Case report: apixaban‐induced thrombocytopenia |
title_sort | case report: apixaban‐induced thrombocytopenia |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331230/ https://www.ncbi.nlm.nih.gov/pubmed/28265388 http://dx.doi.org/10.1002/ccr3.809 |
work_keys_str_mv | AT snellgroveoliver casereportapixabaninducedthrombocytopenia |